Anti-angiogenic therapies for the treatment of angiosarcoma: a clinical update.

ABSTRACT: Angiosarcomas are rare aggressive endothelial tumours, and are associated with a poor prognosis. Due to their vascular nature, there is great interest in their response to anti-angiogenic agents. A number of small prospective studies have reported angiosarcoma response to vascular-targeted agents, including agents that target vascular endothelial growth factor. To date, the response to these agents has been disappointing, and similar to the response observed in other soft tissue sarcoma subtypes. This short review will summarise the recent data in this field.

SUBMITTER: Young RJ 

PROVIDER: S-EPMC5725516 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature